| MeSH term | MeSH ID | Detail |
|---|---|---|
| Gastritis | D005756 | 27 associated lipids |
| Endotoxemia | D019446 | 27 associated lipids |
| Gastrointestinal Hemorrhage | D006471 | 27 associated lipids |
| Autoimmune Diseases | D001327 | 27 associated lipids |
| Angina Pectoris | D000787 | 27 associated lipids |
| Ventricular Remodeling | D020257 | 28 associated lipids |
| Endometriosis | D004715 | 29 associated lipids |
| Vitamin E Deficiency | D014811 | 29 associated lipids |
| Kidney Diseases | D007674 | 29 associated lipids |
| Proteinuria | D011507 | 30 associated lipids |
| Stroke | D020521 | 32 associated lipids |
| Hypothyroidism | D007037 | 32 associated lipids |
| Hypertension, Pulmonary | D006976 | 32 associated lipids |
| Ventricular Dysfunction, Left | D018487 | 33 associated lipids |
| Uremia | D014511 | 33 associated lipids |
| Anemia, Sickle Cell | D000755 | 34 associated lipids |
| Spinal Cord Injuries | D013119 | 34 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Acute Kidney Injury | D058186 | 34 associated lipids |
| Infarction, Middle Cerebral Artery | D020244 | 35 associated lipids |
Thromboxane b2
Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.
Cross Reference
Introduction
To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Thromboxane b2?
Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Thromboxane b2
PubChem Associated disorders and diseases
What pathways are associated with Thromboxane b2
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Thromboxane b2?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Thromboxane b2?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
What genes are associated with Thromboxane b2?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Thromboxane b2?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Thromboxane b2
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Lv GY et al. | Combined antihypertensive effect of luteolin and buddleoside enriched extracts in spontaneously hypertensive rats. | 2013 | J Ethnopharmacol | pmid:24080032 |
| Li H et al. | Select dietary phytochemicals function as inhibitors of COX-1 but not COX-2. | 2013 | PLoS ONE | pmid:24098505 |
| Sayers BC et al. | Role of cyclooxygenase-2 in exacerbation of allergen-induced airway remodeling by multiwalled carbon nanotubes. | 2013 | Am. J. Respir. Cell Mol. Biol. | pmid:23642096 |
| Vasudevan C et al. | The effect of parenteral lipid emulsions on pulmonary hemodynamics and eicosanoid metabolites in preterm infants: a pilot study. | 2013 | Nutr Clin Pract | pmid:24177284 |
| Snider AJ et al. | Inhibition of sphingosine kinase-2 in a murine model of lupus nephritis. | 2013 | PLoS ONE | pmid:23301082 |
| Xue YT et al. | Effect of anger on endothelial-derived vasoactive factors in spontaneously hypertensive rats. | 2013 | Heart Lung Circ | pmid:23261325 |
| Gao H et al. | Effects of Yerba Mate tea (Ilex paraguariensis) on vascular endothelial function and liver lipoprotein receptor gene expression in hyperlipidemic rats. | 2013 | Fitoterapia | pmid:23266732 |
| Carroll RC et al. | A comparison of VerifyNowR with PlateletMappingR--detected aspirin resistance and correlation with urinary thromboxane. | 2013 | Anesth. Analg. | pmid:23302970 |
| Towhid ST et al. | Stimulation of platelet death by vancomycin. | 2013 | Cell. Physiol. Biochem. | pmid:23363637 |
| Ren R et al. | Modulation of platelet aggregation-related eicosanoid production by dietary F-fucoidan from brown alga Laminaria japonica in human subjects. | 2013 | Br. J. Nutr. | pmid:23374164 |
| Gautier-Veyret E et al. | Intermittent hypoxia-activated cyclooxygenase pathway: role in atherosclerosis. | 2013 | Eur. Respir. J. | pmid:23060635 |
| Maenthaisong R et al. | Clinical pharmacology of cyclooxygenase inhibition and pharmacodynamic interaction with aspirin by floctafenine in Thai healthy subjects. | 2013 Apr-Jun | Int J Immunopathol Pharmacol | pmid:23755755 |
| Dudley A et al. | Cyclooxygenase expression and platelet function in healthy dogs receiving low-dose aspirin. | 2013 Jan-Feb | J. Vet. Intern. Med. | pmid:23278865 |
| John F et al. | Elevated levels of leukotriene B4 and thromboxane B2 distinguish chest pain of cardiac and non cardiac origin. | 2013 May-Jun | Indian Heart J | pmid:23809385 |
| Yu C et al. | Effects of danshensu on platelet aggregation and thrombosis: in vivo arteriovenous shunt and venous thrombosis models in rats. | 2014 | PLoS ONE | pmid:25375124 |
| Salazar F et al. | Renal effects induced by prolonged mPGES1 inhibition. | 2014 | Am. J. Physiol. Renal Physiol. | pmid:24197070 |
| Kawai VK et al. | Suboptimal inhibition of platelet cyclooxygenase 1 by aspirin in systemic lupus erythematosus: association with metabolic syndrome. | 2014 | Arthritis Care Res (Hoboken) | pmid:24022862 |
| Elsheikh W et al. | Enhanced chemopreventive effects of a hydrogen sulfide-releasing anti-inflammatory drug (ATB-346) in experimental colorectal cancer. | 2014 | Nitric Oxide | pmid:24747869 |
| Suarez-Kurtz G | Impact of CYP2C9*3/*3 genotype on the pharmacokinetics and pharmacodynamics of oxicam NSAIDs. | 2014 | Pharmacogenet. Genomics | pmid:25003537 |
| Lee HI et al. | Response to Suarez-Kurtz's comments on strongly increased exposure of meloxicam in CYP2C9*3/*3 individuals. | 2014 | Pharmacogenet. Genomics | pmid:25003538 |
| Shan MQ et al. | [Comparative study on effects of Rubiae Radix et Rhizoma and carbonized Rubiae Radix et Rhizoma on acute blood stasis rat model]. | 2014 | Zhongguo Zhong Yao Za Zhi | pmid:24946554 |
| Zhou K et al. | A CAPE analogue as novel antiplatelet agent efficiently inhibits collagen-induced platelet aggregation. | 2014 | Pharmazie | pmid:25158573 |
| DeFilippis AP et al. | Fatty acids and TxA(2) generation, in the absence of platelet-COX-1 activity. | 2014 | Nutr Metab Cardiovasc Dis | pmid:24370448 |
| Togna AR et al. | 4-Methylcoumarin derivatives with anti-inflammatory effects in activated microglial cells. | 2014 | Biol. Pharm. Bull. | pmid:24389482 |
| Osmond DA et al. | Clopidogrel preserves whole kidney autoregulatory behavior in ANG II-induced hypertension. | 2014 | Am. J. Physiol. Renal Physiol. | pmid:24477682 |
| Cathcart MC et al. | Thromboxane synthase expression and correlation with VEGF and angiogenesis in non-small cell lung cancer. | 2014 | Biochim. Biophys. Acta | pmid:24480048 |
| Umar A et al. | Effect of Ocimum basilicum L. on cyclo-oxygenase isoforms and prostaglandins involved in thrombosis. | 2014 | J Ethnopharmacol | pmid:24412551 |
| Sahota T et al. | Model-based analysis of thromboxane Bâ‚‚ and prostaglandin Eâ‚‚ as biomarkers in the safety evaluation of naproxen. | 2014 | Toxicol. Appl. Pharmacol. | pmid:24667227 |
| Gonçalves LH et al. | Acetylsalicylic acid therapy: influence of metformin use and other variables on urinary 11-dehydrothromboxane B2 levels. | 2014 | Clin. Chim. Acta | pmid:24316050 |
| Jiménez-Romero C et al. | Dactyloditerpenol acetate, a new prenylbisabolane-type diterpene from Aplysia dactylomela with significant in vitro anti-neuroinflammatory activity. | 2014 | Bioorg. Med. Chem. Lett. | pmid:24279991 |
| Lee HI et al. | Strongly increased exposure of meloxicam in CYP2C9*3/*3 individuals. | 2014 | Pharmacogenet. Genomics | pmid:24322170 |
| Voisin V et al. | Protection of Wistar-Furth rats against postischaemic acute renal injury: role for nitric oxide and thromboxane? | 2014 | Clin. Exp. Pharmacol. Physiol. | pmid:25115485 |
| Chou YI et al. | Correlations of platelet-derived microparticles with thromboxane B2, platelet-activating factor, endothelin-1, and neutrophil to lymphocyte ratio in patients with coronary intermediate lesions. | 2014 | Biomarkers | pmid:25391885 |
| Zhu Y et al. | Effects and mechanisms of Fenofibrate on the secretion of vascular endothelial contraction factors in hypertensive rats. | 2014 | Genet. Mol. Res. | pmid:25078582 |
| Wang Y et al. | DanQi Pill protects against heart failure through the arachidonic acid metabolism pathway by attenuating different cyclooxygenases and leukotrienes B4. | 2014 | BMC Complement Altern Med | pmid:24555740 |
| Fuentes E et al. | A novel role of Eruca sativa Mill. (rocket) extract: antiplatelet (NF-κB inhibition) and antithrombotic activities. | 2014 | Nutrients | pmid:25514563 |
| Santos-Gallego CG and Badimon JJ | The sum of two evils: pneumonia and myocardial infarction: is platelet activation the missing link? | 2014 | J. Am. Coll. Cardiol. | pmid:25444148 |
| Cangemi R et al. | Platelet activation is associated with myocardial infarction in patients with pneumonia. | 2014 | J. Am. Coll. Cardiol. | pmid:25444147 |
| Shinohara M et al. | Cell-cell interactions and bronchoconstrictor eicosanoid reduction with inhaled carbon monoxide and resolvin D1. | 2014 | Am. J. Physiol. Lung Cell Mol. Physiol. | pmid:25217660 |
| Hong S et al. | Maresin-like lipid mediators are produced by leukocytes and platelets and rescue reparative function of diabetes-impaired macrophages. | 2014 | Chem. Biol. | pmid:25200603 |
| Tong B et al. | [Atorvastatin inhibits platelet aggregation and activation following carotid balloon injury in cholesterol-fed rabbits]. | 2014 | Nan Fang Yi Ke Da Xue Xue Bao | pmid:25176087 |
| Kaplon-Cieslicka A et al. | Younger age, higher body mass index and lower adiponectin concentration predict higher serum thromboxane B2 level in aspirin-treated patients with type 2 diabetes: an observational study. | 2014 | Cardiovasc Diabetol | pmid:25123549 |
| Hayashi G et al. | Frataxin deficiency increases cyclooxygenase 2 and prostaglandins in cell and animal models of Friedreich's ataxia. | 2014 | Hum. Mol. Genet. | pmid:25104852 |
| Floyd CN et al. | Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin-resistant but not aspirin-sensitive subjects. | 2014 | Br J Clin Pharmacol | pmid:25099258 |
| Zhu SH et al. | Protective effect of indomethacin in renal ischemia-reperfusion injury in mice. | 2014 | J Zhejiang Univ Sci B | pmid:25091992 |
| Basili S et al. | Aspirin reload before elective percutaneous coronary intervention: impact on serum thromboxane b2 and myocardial reperfusion indexes. | 2014 | Circ Cardiovasc Interv | pmid:25074252 |
| Lattanzio S et al. | Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. | 2014 | J Am Heart Assoc | pmid:25037197 |
| Santilli F et al. | Circulating myeloid-related protein-8/14 is related to thromboxane-dependent platelet activation in patients with acute coronary syndrome, with and without ongoing low-dose aspirin treatment. | 2014 | J Am Heart Assoc | pmid:25037196 |
| Patrignani P et al. | Reappraisal of the clinical pharmacology of low-dose aspirin by comparing novel direct and traditional indirect biomarkers of drug action. | 2014 | J. Thromb. Haemost. | pmid:24942808 |
| Reddoch KM et al. | Hemostatic function of apheresis platelets stored at 4°C and 22°C. | 2014 | Shock | pmid:24169210 |